Lupin is currently trading at Rs. 900.05, up by 5.00 points or 0.56% from its previous closing of Rs. 895.05 on the BSE.
The scrip opened at Rs. 900.50 and has touched a high and low of Rs. 912.60 and Rs. 894.90 respectively. So far 113724 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1176.00 on 19-Jul-2017 and a 52 week low of Rs. 723.55 on 15-May-2018.
Last one week high and low of the scrip stood at Rs. 921.35 and Rs. 878.40 respectively. The current market cap of the company is Rs. 41131.18 crore.
The promoters holding in the company stood at 47.01%, while Institutions and Non-Institutions held 37.60% and 15.40% respectively.
Lupin and the Municipal Corporation of Greater Mumbai (MCGM) have united and launched a joint campaign to detect and address active cases of TB in Mumbai. The door-to-door Active Case Finding (ACF) campaign will cover all high-risk population areas selected from all 24 wards under the MCGM.
This campaign and the methodology of execution follows the success of ACF pilot that was conducted by Lupin along with the TB department of the MCGM in 2017. The new 12-month project will involve comprehensive end-to-end TB detection, treatment and follow-up with door-to-door visits conducted in high-risk areas to identify symptomatic patients.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1532.85 |
| Dr. Reddys Lab | 5812.50 |
| Cipla | 1403.90 |
| Zydus Lifesciences | 1104.45 |
| Lupin | 1661.90 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
